[ad_1]
The World Health Organization now recommends the use of Regeneron-the former-experimental treatment used by former US President Donald Trump when he contracted Covid-19.
Regeneron, or Ronapreve as it is called in New Zealand, has not yet been cleared in Aotearoa but an application was filed with MedSafe on September 3 for it and it is currently undergoing a priority review.
The treatment, which combines the two antibodies [casirivimab and imdevimab] Recommended for two specific groups of patients with Covid-19 by a panel of WHO experts and patients, the British Medical Journal announced.
The first are patients with non-severe Covid-19 who have the highest risk of being hospitalized and the second are those with severe or critical Covid-19 who do not have their own antibody response to Covid-19.
Your playlist will load after this ad
The President of the United States wants to give the drug to everyone who has Covid-19 in the US for free. Source: 1 NEWS
The treatment has already been approved for use in the UK and Japan and has emergency approval status in the US, European Union, Canada and several other countries.
Professor Kurt Krause of Otago University said that “in order to be most effective these antibodies should be given early in the course of Covid-19”.
Your playlist will load after this ad
It has been approved for emergency use in more than 20 countries and is the first new treatment for Covid-19 to be considered here. Source: 1 NEWS
When Trump used Regeneron in October, he said at the time the treatment was effective that he wanted “everyone to be given the same treatment as your President because I feel great”.
|
Sources 2/ https://www.tvnz.co.nz/one-news/new-zealand/recommends-antibody-covid-treatment-previously-used-donald-trump The mention sources can contact us to remove/changing this article |
[ad_2]